12 Health Care Stocks Moving In Friday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
The article highlights the pre-market movements of 12 health care stocks on Friday. Notable gainers include Cue Health (HLTH), Innovative Eyewear (LUCY), SCWorx (WORX), Arcus Biosciences (RCUS), Biora Therapeutics (BIOR), and Jin Medical International (ZJYL). Significant losers include Verastem (VSTM), Sensei Biotherapeutics (SNSE), Genelux (GNLX), Summit Therapeutics (SMMT), Akari Therapeutics (AKTX), and Akso Health Group (AHG).
May 24, 2024 | 12:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Biora Therapeutics stock moved upwards by 15.01% to $0.57, with a market cap of $20.5 million.
The stock's significant rise in pre-market trading indicates positive sentiment, likely leading to a short-term price increase.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Cue Health shares surged by 42.1% to $0.13 in pre-market trading, with a market cap of $21.3 million.
A significant price increase in pre-market trading indicates strong investor interest, likely leading to a positive short-term impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Innovative Eyewear stock rose 24.73% to $0.23, with a market cap of $4.0 million.
A substantial increase in stock price suggests positive sentiment, likely leading to a short-term upward trend.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Arcus Biosciences stock rose 16.33% to $18.94, with a market cap of $1.7 billion.
A notable increase in stock price suggests strong investor confidence, likely leading to a short-term upward trend.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
SCWorx shares increased by 17.02% to $2.2, with a market cap of $2.6 million.
The stock's significant rise in pre-market trading indicates positive investor sentiment, likely leading to a short-term price increase.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
POSITIVE IMPACT
Jin Medical International shares moved upwards by 14.92% to $3.23, with a market cap of $505.5 million.
A significant price increase in pre-market trading indicates strong investor interest, likely leading to a positive short-term impact.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
Akso Health Group stock decreased by 10.4% to $1.12, with a market cap of $164.2 million.
A significant decline in stock price indicates negative investor sentiment, likely leading to a short-term downward trend.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Akari Therapeutics shares declined by 11.3% to $1.65, with a market cap of $13.0 million.
A notable decrease in stock price suggests negative sentiment, likely leading to a short-term downward trend.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
Genelux stock decreased by 21.74% to $3.6, with a market cap of $97.1 million.
A notable decrease in stock price suggests negative sentiment, likely leading to a short-term downward trend.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Summit Therapeutics stock declined by 15.51% to $3.65, with a market cap of $2.5 billion.
A significant decline in stock price indicates negative investor sentiment, likely leading to a short-term downward trend.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Sensei Biotherapeutics stock fell 40.01% to $0.87, with a market cap of $21.8 million.
A significant drop in stock price indicates negative investor sentiment, likely leading to a short-term downward trend.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100
NEGATIVE IMPACT
Verastem stock fell 59.0% to $4.99, with a market cap of $126.3 million.
A drastic drop in stock price suggests negative sentiment, likely leading to a short-term downward trend.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100